FDA.reportPublic FDA data

linaclotide 0.072 MG Oral Capsule [Linzess]

RxCUI
1869699
RxNorm name
linaclotide 0.072 MG Oral Capsule [Linzess]
Display name
linaclotide 0.072 MG Oral Capsule [Linzess]
Full name
linaclotide 0.072 MG Oral Capsule [Linzess]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LinzessLINACLOTIDEAllergan, Inc.09beda19-56d6-4a56-afdc-9a77b70b2ef32026-05-21Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1869699

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
09beda19-56d6-4a56-afdc-9a77b70b2ef3Linzess 72 MCG Oral Capsule [PSN] · linaclotide 0.072 MG Oral Capsule [Linzess] [SBD] · Linzess 0.072 MG Oral Capsule [SY] · Linzess 72 MCG Oral Capsule [SY]439These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information for LINZESS . LINZESS ® ( linaclotide ) capsules, for oral use Initial U.S. Approval: 201220260521